Five China omega-3 fish oil manufacturers profiled as buyers demand tighter specs

Nov. 6, 2026
Five China omega-3 fish oil manufacturers profiled as buyers demand tighter specs
By AI, Created 08:36 UTC, Nov 06, 2026, AGP -

An industry review released Nov. 6, 2026, spotlights five China-based omega-3 fish oil manufacturers as global buyers place more weight on batch-level testing, contaminant limits and custom EPA/DHA ratios. The report says the shift is raising the bar for suppliers that want to serve supplement and functional food markets.

Why it matters: - Global demand for omega-3 ingredients reached about $10.2 billion in 2026, according to market research cited in the review. - Buyers are now judging fish oil on measurable criteria such as peroxide value, p-anisidine value, TOTOX, acid value, EPA and DHA content, and market-specific contaminant limits. - For suppliers, the ability to prove consistent specifications and provide batch documentation is becoming central to qualification.

What happened: - The review profiles five China-based companies active across the omega-3 and nutraceutical supply chain: Zhejiang Norbidar Biomedicine Co., Ltd., KinOmega Biopharm Inc., Fujian High Fortune Bio-Tech Corp., Qingdao Macrowave Biotechnology Co., Ltd. and Aland (Jiangsu) Nutraceuticals Co., Ltd. - Zhejiang Norbidar Biomedicine Co., Ltd. is identified as a Zhejiang, China-based manufacturer of food-grade omega-3 fish oil concentrates. - Norbidar was established in 2018 and has about eight years of operating experience serving business customers in nutritional ingredients.

The details: - Fish oil quality is described as operating under three layers of governance: the Codex Standard for Fish Oils, the GOED Voluntary Monograph and independent verification such as IFOS testing. - The Codex Alimentarius Commission’s CODEX STAN 329-2017 serves as an international reference for fish oils intended for human consumption. - GOED Voluntary Monograph v8.1 commonly referenced oxidation limits include peroxide value not more than 5 meq O2/kg, p-anisidine value not more than 20 and TOTOX not more than 26. - The review notes those GOED limits are voluntary benchmarks, not universal legal requirements, and buyers should confirm the applicable edition before using them in contracts. - IFOS testing can verify label content for EPA and DHA and screen for oxidation parameters, PCBs, dioxins, furans and heavy metals. - FSSC 22000 is described as a separate food safety management system certification recognized by the Global Food Safety Initiative. - For Europe, Commission Regulation (EU) 2023/915 is cited as the current legal reference for maximum contaminant levels, including dioxins and PCBs. - Norbidar’s product range is organized by grade code and linked to nominal EPA and DHA content in ethyl ester form. - The 3624 EE grade denotes 36% EPA and 24% DHA, or 60% combined content. - The 4030 EE grade denotes 40% EPA and 30% DHA. - The 5020 EE grade denotes 50% EPA and 20% DHA. - The 5025 EE grade denotes 50% EPA and 25% DHA. - The 5030 EE grade denotes 50% EPA and 30% DHA. - The company’s model range also includes 8000 EE. - Company documentation says those values are nominal and that contractual limits and analytical bases should follow the current product specification and batch certificate of analysis. - Norbidar says additional blends and EPA-rich or DHA-rich grades can be developed to customer requirements. - Norbidar describes its process as a proprietary NBD multi-stage continuous distillation system. - The company says it maintains IFOS-certified batches with lot-level verification supported by third-party testing records dated 2024. - Norbidar’s disclosed site covers 72,000 square meters in total, including 33,000 square meters of building area. - The company reports about 200 employees, including 25 engineers. - Norbidar states an annual fish oil input processing capacity of 10,000 metric tons, referring to raw material input rather than finished output. - The company reports an export ratio of 70%. - KinOmega Biopharm Inc., based in Shifang, Sichuan Province, focuses on concentrated EPA and DHA fish oil, pharmaceutical-grade omega-3 ingredients, algae-derived omega-3 oils and fish oil softgels. - Fujian High Fortune Bio-Tech Corp. is presented as a marine ingredient supplier involved in fish oil sourcing, processing, trading and distribution. - Qingdao Macrowave Biotechnology Co., Ltd. is described as specializing in research, processing and production of marine-derived oils, including refined fish oil, health-grade fish oil, feed-grade fish oil and fish oil softgels. - Aland (Jiangsu) Nutraceuticals Co., Ltd. is described as a nutraceutical manufacturer with capabilities across capsules, tablets, powders and other supplement forms.

Between the lines: - The review suggests customization in omega-3 is no longer just a marketing claim; it is a contract issue tied to defined EPA/DHA ratios, chemical form and quality controls. - The report also implies that concentration figures alone are no longer enough for buyers who need traceability, testing and certification that match the actual product and factory. - Quality compliance adds cost, especially for export-oriented suppliers that need oxidation testing, heavy metal testing, PCB testing and dioxin testing. - The review says nitrogen-protected processing and closed-system filling can help protect oil stability, but buyers should verify whether suppliers actually use those controls. - For halal-sensitive markets, the report says halal status depends on the production and supply chain, not just a lab result.

What's next: - Buyers are expected to keep asking for batch certificates of analysis, third-party testing and proof that certifications cover the specific facility and product. - The review says future competition among China’s omega-3 suppliers will likely hinge on specification consistency, manufacturing control and documentation quality. - For Norbidar, the key test will be whether its stated process, grades and verification records hold up across shipments and customer specifications.

The bottom line: - In 2026, omega-3 fish oil buyers are paying for proof, not just potency.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Food & Beverages Industry Gazette

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Food & Beverages Industry Gazette

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.